JP4689175B2 - Composition, method for regenerating hair follicle and animal carrying regenerated hair follicle - Google Patents
Composition, method for regenerating hair follicle and animal carrying regenerated hair follicle Download PDFInfo
- Publication number
- JP4689175B2 JP4689175B2 JP2004048322A JP2004048322A JP4689175B2 JP 4689175 B2 JP4689175 B2 JP 4689175B2 JP 2004048322 A JP2004048322 A JP 2004048322A JP 2004048322 A JP2004048322 A JP 2004048322A JP 4689175 B2 JP4689175 B2 JP 4689175B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- hair
- cell
- hair follicle
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000003780 hair follicle Anatomy 0.000 title claims description 93
- 238000000034 method Methods 0.000 title claims description 52
- 241001465754 Metazoa Species 0.000 title claims description 48
- 239000000203 mixture Substances 0.000 title claims description 42
- 230000001172 regenerating effect Effects 0.000 title claims description 15
- 210000004027 cell Anatomy 0.000 claims description 205
- 210000002919 epithelial cell Anatomy 0.000 claims description 93
- 210000004209 hair Anatomy 0.000 claims description 66
- 210000003491 skin Anatomy 0.000 claims description 49
- 238000002360 preparation method Methods 0.000 claims description 48
- 230000002500 effect on skin Effects 0.000 claims description 44
- 210000001519 tissue Anatomy 0.000 claims description 24
- 238000002054 transplantation Methods 0.000 claims description 23
- 210000003953 foreskin Anatomy 0.000 claims description 17
- 238000011580 nude mouse model Methods 0.000 claims description 15
- 239000006285 cell suspension Substances 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 238000005138 cryopreservation Methods 0.000 claims description 8
- 210000000987 immune system Anatomy 0.000 claims description 6
- 102000029816 Collagenase Human genes 0.000 claims description 5
- 108060005980 Collagenase Proteins 0.000 claims description 5
- 229960002424 collagenase Drugs 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 230000003325 follicular Effects 0.000 claims description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 40
- 210000002615 epidermis Anatomy 0.000 description 25
- 241000699670 Mus sp. Species 0.000 description 21
- 230000003661 hair follicle regeneration Effects 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 241000700159 Rattus Species 0.000 description 19
- 210000004927 skin cell Anatomy 0.000 description 17
- 210000004207 dermis Anatomy 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- 241000699660 Mus musculus Species 0.000 description 14
- 239000002953 phosphate buffered saline Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 241000282412 Homo Species 0.000 description 10
- 210000001339 epidermal cell Anatomy 0.000 description 10
- 210000000130 stem cell Anatomy 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 108700012813 7-aminoactinomycin D Proteins 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000010186 staining Methods 0.000 description 8
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 7
- 230000003779 hair growth Effects 0.000 description 7
- 238000011830 transgenic mouse model Methods 0.000 description 7
- 102000004142 Trypsin Human genes 0.000 description 6
- 108090000631 Trypsin Proteins 0.000 description 6
- 238000010171 animal model Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000007710 freezing Methods 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- 230000000284 resting effect Effects 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 239000012588 trypsin Substances 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 4
- 230000000735 allogeneic effect Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 238000000684 flow cytometry Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- 241000283086 Equidae Species 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 241000282579 Pan Species 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 241000288906 Primates Species 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 210000003850 cellular structure Anatomy 0.000 description 3
- 239000008150 cryoprotective solution Substances 0.000 description 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 239000003068 molecular probe Substances 0.000 description 3
- 238000012758 nuclear staining Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000000512 collagen gel Substances 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 210000000442 hair follicle cell Anatomy 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102000005598 Chondroitin Sulfate Proteoglycans Human genes 0.000 description 1
- 108010059480 Chondroitin Sulfate Proteoglycans Proteins 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 102000004266 Collagen Type IV Human genes 0.000 description 1
- 108010042086 Collagen Type IV Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 238000010867 Hoechst staining Methods 0.000 description 1
- 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 description 1
- 102100032816 Integrin alpha-6 Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000011316 allogeneic transplantation Methods 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 210000000185 follicular epithelial cell Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229920005644 polyethylene terephthalate glycol copolymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003168 reconstitution method Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000002689 xenotransplantation Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Images
Description
本発明は毛包を再生するための毛乳頭細胞及び上皮系細胞を含有する組成物、それを用いて毛包を再生する方法、さらにはそのような方法により再生された毛包を担持する動物又は3次元皮膚モデルを提供する。 The present invention relates to a composition containing dermal papilla cells and epithelial cells for regenerating hair follicles, a method for regenerating hair follicles using the composition, and an animal carrying a hair follicle regenerated by such a method Alternatively, a three-dimensional skin model is provided.
毛包は成熟した生体で自己再生をほぼ一生涯を通じて繰り返す例外的な器官である。その自己再生の仕組みを解明することは、組織や細胞移植による脱毛治療、毛包や皮脂腺を含有する自然に近い機能的にも優れた皮膚シートの構築など、ニーズの高い臨床応用に繋がるものと期待される。近年、幹細胞研究への関心の高まりと共に毛包上皮幹細胞(上皮細胞)の研究が急速に進展し、また毛包特異的な間葉系細胞たる毛乳頭細胞についてもその性質が少しずつ判ってきた。毛乳頭細胞は毛包の自己再生のために毛包上皮幹細胞に活性化シグナルを送るいわば司令塔の役割を担い、毛包再構成評価系においては毛包上皮幹細胞と共に欠くことのできない細胞であることが判っている(Kishimoto et al., Proc. Natl. Acad. Sci. USA (1999), Vol.96, pp. 7336-7341;非特許文献1)。 The hair follicle is an exceptional organ that repeats self-renewal for almost a lifetime in a mature organism. Elucidating the mechanism of self-regeneration will lead to clinical applications with high needs such as hair loss treatment by tissue and cell transplantation, construction of skin sheets that are functionally superior in nature containing hair follicles and sebaceous glands. Be expected. In recent years, research on hair follicle epithelial stem cells (epithelial cells) has progressed rapidly with increasing interest in stem cell research, and the characteristics of hair follicle papilla cells, which are hair follicle-specific mesenchymal cells, have gradually become known. . Papilla cells play the role of a control tower that sends activation signals to hair follicle epithelial stem cells for self-renewal of hair follicles, and are essential cells with hair follicle epithelial stem cells in the evaluation system of hair follicle reconstitution (Kishimoto et al., Proc. Natl. Acad. Sci. USA (1999), Vol. 96, pp. 7336-7341; Non-Patent Document 1).
毛包の再生を目指して、動物モデルでの毛包再構成実験がこれまで様々な方法で行われている。Weinberg et al., J. Invest. Dermatol. (1993), Vol.100, pp. 229-236(非特許文献2)には細胞移植法による毛包再構成方法が記載されている。Weinbergらの移植系は毛乳頭細胞、新生仔上皮系細胞(毛包上皮幹細胞を含む)のほかにマウス3T3細胞の加えられて複雑な構成を有する。Weinbergらの方法によれば毛包上皮幹細胞を含む新生仔上皮系細胞を移植系に加えなくても毛包が再生するとのことである。しかしながら、これは毛乳頭細胞画分から未分化上皮系細胞(毛包上皮幹細胞)や毛包原基を完全に除去することが困難なために起きた現象であると考えられる。その後、Kishimotoら(前掲)は毛乳頭細胞の単離精製にはじめて成功し、単離精製した毛乳頭細胞を用い、動物モデルでの細胞移植法による毛包再構成実験を行った結果、毛乳頭細胞と上皮細胞との組み合わせを含む細胞画分を移植すると毛包が再構成され、発毛が認められるが、毛乳頭細胞又は上皮細胞のいずれかしか含まない細胞画分を移植した場合、発毛が認められないことを見出している。 Aiming at the regeneration of hair follicles, hair follicle reconstruction experiments using animal models have been conducted in various ways. Weinberg et al., J. Invest. Dermatol. (1993), Vol. 100, pp. 229-236 (Non-Patent Document 2) describes a method for reconstructing hair follicles by cell transplantation. The transplantation system of Weinberg et al. Has a complicated structure in which mouse 3T3 cells are added in addition to dermal papilla cells and neonatal epithelial cells (including follicular epithelial stem cells). According to the method of Weinberg et al., Hair follicles regenerate without adding neonatal epithelial cells including hair follicle epithelial stem cells to the transplantation system. However, this is considered to be a phenomenon that occurred because it was difficult to completely remove undifferentiated epithelial cells (hair follicle epithelial stem cells) and hair follicle primordia from the hair papillary cell fraction. Subsequently, Kishimoto et al. (Supra) succeeded in isolating and purifying dermal papilla cells for the first time, and as a result of performing follicular reconstitution experiments using cell transplantation methods in animal models using isolated and purified dermal papilla cells. When a cell fraction containing a combination of cells and epithelial cells is transplanted, hair follicles are reconstituted and hair growth is observed, but when a cell fraction containing only hair papilla cells or epithelial cells is transplanted, I have found that no hair is found.
しかしながら、Kishimotoらによる毛乳頭細胞の精製方法は、毛乳頭細胞がバーシカン(コンドロイチン硫酸プロテオグリカン類)を特異的に発現する性質を有することを利用し、バーシカン遺伝子にリポーター遺伝子を繋げたDNAを用いて作製したトランスジェニックマウスモデルによってバーシカン発現を指標とし、単離・濃縮を行うものである。従って、この方法はトランスジェニックマウスの作製、セルソーターによる毛乳頭細胞の純化を要する。特に、毛包再構成方法において毛包を実際に再生させ、発毛を起こさせるには大量の毛乳頭細胞が必要であり(例えば、1移植当たり500万個の細胞)、そのためこの方法では大量のトランスジェニックマウスの作製、長時間の高速セルソーターの使用を要し、経済的にも、また作業時間、労力の面においても問題があった。毛乳頭細胞の単離は例えばProuty et al., American J. Pathol. (1996) Vol.148, No.6, pp.1871-1885(非特許文献3)にも記載されているが、遠心分離により分画を繰り返す複雑で、純度が低く且つ収量の低い方法である。 However, the method for purification of hair papilla cells by Kishimoto et al. Uses the fact that hair papilla cells have the property of specifically expressing versican (chondroitin sulfate proteoglycans), and uses DNA in which a reporter gene is linked to a versican gene. Isolation / concentration is performed by using the produced transgenic mouse model with versican expression as an index. Therefore, this method requires preparation of transgenic mice and purification of dermal papilla cells using a cell sorter. In particular, a large amount of dermal papilla cells are required for the hair follicle reconstitution method to actually regenerate and cause hair growth (eg, 5 million cells per transplant), so this method requires a large amount. The production of a transgenic mouse and the use of a high-speed cell sorter for a long time required problems in terms of economy, working time and labor. For example, Prouty et al., American J. Pathol. (1996) Vol.148, No.6, pp.1871-1885 (Non-patent Document 3) describes the isolation of dermal papilla cells. This is a complicated, low purity and low yield method that repeats fractionation.
従って、これまでの毛乳頭細胞精製法では単離精製された活性毛乳頭細胞を、例えば移植のために十分な量で獲得することが困難であり、毛包再生系における活性毛乳頭細胞の役割を完全に解明することができなかった。特に、毛包を再生する毛包再構成系における毛乳頭細胞と上皮系細胞の適切な割合を決定することは、従来技術による精製法では事実上不可能であった。
本発明の課題は、活性毛乳頭細胞及び活性上皮系細胞を毛包の再生に適した比率で含有する毛包再生系を提供することにある。 An object of the present invention is to provide a hair follicle regeneration system containing active hair papilla cells and active epithelial cells in a ratio suitable for hair follicle regeneration.
本発明者は、驚くべきことに、皮膚組織から採取した真皮組織画分の細胞懸濁物を凍結保存すると、その懸濁物中に夾雑した毛包上皮細胞が特異的に死滅し、毛乳頭細胞は大半が活性であり続けることを見出した。このようにして得た細胞調製品は活性細胞成分として毛乳頭細胞のみを含有するため、毛包を再生するのに有効な毛乳頭細胞、対、上皮系細胞の割合を決定するのに利用できる。その結果、本発明者は毛包の再生に最適とされる毛包再構成系における毛乳頭細胞、対、上皮系細胞の割合を決定することができた。 Surprisingly, the inventor of the present invention, when cryopreserving a cell suspension of a dermis tissue fraction collected from skin tissue, follicular epithelial cells contaminated in the suspension are specifically killed, and the hair papilla The cells were found to remain largely active. Since the cell preparation thus obtained contains only hair papilla cells as active cell components, it can be used to determine the proportion of hair papilla cells, vs. epithelial cells, effective in regenerating hair follicles. . As a result, the present inventor was able to determine the ratio of the dermal papilla cells to the epithelial cells in the hair follicle reconstitution system that is optimal for hair follicle regeneration.
従って、本発明は、毛乳頭細胞及び上皮系細胞を含んで成り、当該毛乳頭細胞、対、上皮系細胞の細胞数の比が1:10〜10:1であることを特徴とする毛包を再生するための組成物を提供する。 Accordingly, the present invention comprises a hair follicle cell and an epithelial cell, wherein the ratio of the number of cells of the hair papilla cell to the epithelial cell is 1:10 to 10: 1. A composition for regenerating is provided.
更に好ましくは、本発明は、毛乳頭細胞及び上皮系細胞を含んで成る毛包を再生するための組成物であって、皮膚組織から表皮組織を取り除くことで得た真皮組織画分をコラーゲン処理して細胞懸濁物を調製し、次いで当該細胞懸濁物を凍結保存することで毛包上皮細胞を死滅させることで調製された毛乳頭細胞調製品及び上皮系細胞を含んで成り、ここで当該毛乳頭細胞、対、上皮系細胞の細胞数の比が1:10〜10:1である、毛包を再生するための組成物を提供する。 More preferably, the present invention is a composition for regenerating hair follicles comprising hair papilla cells and epithelial cells, wherein the dermal tissue fraction obtained by removing epidermal tissue from the skin tissue is treated with collagen. A cell suspension, and then comprising a hair papilla cell preparation and epithelial cells prepared by killing hair follicle epithelial cells by cryopreserving the cell suspension, wherein Provided is a composition for regenerating a hair follicle, wherein the ratio of the number of cells of the dermal papilla cells to epithelial cells is 1:10 to 10: 1.
好ましくは、上記毛乳頭細胞、対、上皮系細胞の細胞数の比は1:3〜10:1、更に好ましくは1:1〜10:1、更により好ましくは1:1〜3:1、最も好ましくは1:1である。 Preferably, the ratio of the number of dermal papilla cells to epithelial cells is 1: 3 to 10: 1, more preferably 1: 1 to 10: 1, even more preferably 1: 1 to 3: 1. Most preferred is 1: 1.
本発明は更に、上記組成物を用いて動物又は3次元皮膚モデルに毛包を再生する方法、及びこのようにして毛包の再生された動物又は3次元皮膚元モデルを提供する。 The present invention further provides a method for regenerating a hair follicle on an animal or a three-dimensional skin model using the above composition, and thus an animal or a three-dimensional skin model in which the hair follicle is regenerated.
トランスジェニックマウスを使用せず、簡単に、活性細胞成分として毛乳頭細胞のみを含有する毛乳頭細胞調製品を調製する方法が提供された。この毛乳頭細胞調製品は毛包再生のための移植手術や、毛包再構成の研究・開発に利用できる。特に、当該毛乳頭細胞調製品には活性上皮幹細胞の夾雑がないため、毛包の再生に使用する活性毛乳頭細胞と活性上皮毛幹細胞の細胞数の割合を精密に調整することが必要であり、しかも細胞を大量に必要とする状況において、有利である。 A method for preparing a hair papilla cell preparation containing only hair papilla cells as an active cell component in a simple manner without using a transgenic mouse was provided. This dermal papilla cell preparation can be used for transplantation surgery for hair follicle regeneration and for research and development of hair follicle reconstruction. In particular, since the hair papilla cell preparation is free of active epithelial stem cells, it is necessary to precisely adjust the ratio of the number of active hair papilla cells and active epithelial hair stem cells used for hair follicle regeneration. Moreover, it is advantageous in a situation where a large amount of cells are required.
本発明は、毛包を再生するための毛乳頭細胞及び上皮系細胞を含有する組成物、それを用いて毛包を再生する方法、さらにはそのような再生された毛包を担持する動物又は3次元皮膚モデルを提供する。 The present invention relates to a composition containing dermal papilla cells and epithelial cells for regenerating hair follicles, a method for regenerating hair follicles using the composition, and an animal or a carrier carrying such regenerated hair follicles. A three-dimensional skin model is provided.
「毛乳頭細胞」とは、間葉系細胞として毛包最底部に位置し、毛包の自己再生のために毛包上皮幹細胞に活性化シグナルを送る、いわば司令塔の役割を担っている細胞をいう。活性化毛乳頭細胞のみを含有する毛乳頭細胞調製品は、例えばトランスジェニックマウスを使用したKishimoto(前掲)の方法に調製できる。しかしながら、収量などの点で好ましくは、例えば皮膚組織から表皮組織を取り除くことで得た真皮組織画分をコラーゲン処理して細胞懸濁物を調製し、次いで当該細胞懸濁物を凍結保存することで毛包上皮細胞を死滅させることで調製することができる。 “Papilla cells” are cells located at the bottom of the hair follicle as mesenchymal cells and send activation signals to the hair follicle epithelial stem cells for the self-renewal of hair follicles. Say. A dermal papilla cell preparation containing only activated dermal papilla cells can be prepared, for example, by the method of Kishimoto (supra) using a transgenic mouse. However, in terms of yield and the like, preferably, for example, a cell suspension is prepared by collagen treatment of a dermis tissue fraction obtained by removing epidermal tissue from skin tissue, and then the cell suspension is cryopreserved. Can be prepared by killing hair follicle epithelial cells.
上記凍結保存による方法は、具体的には、例えば以下の通りにして実施できる。
1.哺乳動物の表皮を用意する。
2.この表皮を、必要ならタンパク質分解酵素溶液、例えばトリプシン溶液の中に適当な時間、例えば一晩静置し、その後表皮部分をピンセットなどで取り除き、残った真皮をコラゲナーゼで処理し、細胞懸濁液を調製する。
3.必要ならセルストレーナーにより懸濁液をろ過し、静置により沈殿物を除去する。
4.細胞数を計測し、適当な細胞密度、好ましくは1x105〜1x108/ml程度の細胞密度にて凍結保護液で再懸濁し、必要なら小分け分注し、通常の細胞保存方法に従い、凍結保存する。
5.適当な期間保存後、融解し、使用する。
Specifically, the method by cryopreservation can be performed, for example, as follows.
1. Prepare a mammalian epidermis.
2. If necessary, leave this epidermis in a proteolytic enzyme solution, such as a trypsin solution, for an appropriate time, for example overnight, then remove the epidermis with tweezers, treat the remaining dermis with collagenase, and To prepare.
3. If necessary, the suspension is filtered with a cell strainer, and the precipitate is removed by standing.
4). Count the number of cells, resuspend in a cryoprotective solution at an appropriate cell density, preferably about 1 × 10 5 to 1 × 10 8 / ml, aliquot if necessary, and cryopreserve according to normal cell storage methods To do.
5. After storage for an appropriate period, melt and use.
凍結方法は特に限定されることはないが、−20℃以下、好ましくは−50℃以下、より好ましくは−80℃以下の超低温冷凍庫中で、又は液体窒素中で保存する。凍結保存期間も特に限定されることがないが、上皮細胞が死滅するよう、例えば1日以上、好ましくは3日以上、より好ましくは1週間以上の期間とする。尚、液体窒素中で4ヶ月保存しても、毛乳頭細胞は生存し続けていることが確認された。凍結保護液としては細胞の保存において使用されている通常の保存液、例えばセルバンカー2細胞凍結保存液(カタログNo.BLC−2)(日本全薬工業製)が使用できる。
The freezing method is not particularly limited, but it is stored in an ultra-low temperature freezer at -20 ° C or lower, preferably -50 ° C or lower, more preferably -80 ° C or lower, or in liquid nitrogen. The cryopreservation period is not particularly limited, but is set to, for example, 1 day or longer, preferably 3 days or longer, more preferably 1 week or longer so that the epithelial cells are killed. It was confirmed that the dermal papilla cells continued to survive even after being stored in liquid nitrogen for 4 months. As the cryoprotective solution, a normal preservation solution used in cell preservation, for example, Cell
細胞数の計測は当業者周知の方法により実施することができる。例えば、細胞数の計測は血球計算盤(SLGC社製、EOSINOPHIL COUNTER)に等量の0.4%トリパンブルー染色液(No.15250-061、インビトロジェン)で希釈した細胞懸濁液を供して血球計算盤付属の取扱説明書記載の方法に従って算出することができる。 The number of cells can be measured by a method well known to those skilled in the art. For example, the cell count is measured using a cell suspension diluted with an equal volume of 0.4% trypan blue staining solution (No. 15250-061, Invitrogen) on a hemocytometer (SLGC, EOSINOPHIL COUNTER) It can be calculated according to the method described in the instruction manual attached to the calculator.
本発明の毛乳頭細胞はあらゆる哺乳動物、例えばヒト、チンパンジー、その他の霊長類、家畜動物、例えばイヌ、ネコ、ウサギ、ウマ、ヒツジ、ヤギ、ウシ、ブタ、他に実験用動物、例えばラット、マウス、モルモット、より好ましくはヌードマウス、スキッドマウス、ヌードラットの表皮に由来し得る。 The dermal papilla cells of the present invention can be any mammal, such as humans, chimpanzees, other primates, livestock animals such as dogs, cats, rabbits, horses, sheep, goats, cows, pigs, as well as laboratory animals such as rats, It can be derived from the epidermis of mice, guinea pigs, more preferably nude mice, skid mice, nude rats.
「上皮系細胞」は、皮膚の表皮または上皮の大部分を構成する細胞であり、真皮に接する1層の基底細胞から生じる。マウスを例にすると、上皮系細胞としては新生仔(もしくは胎児)に由来する上皮系細胞が好ましく使用できるが、成熟した皮膚、例えば休止期毛の表皮又は成長期毛の表皮に由来する細胞でも、ケラチノサイトの形態にある細胞の培養物であってもよい。かような細胞は、当業者周知の方法により所望のドナー動物の皮膚から調製することができる。 “Epithelial cells” are cells that make up the majority of the epidermis or epithelium of the skin and arise from a single layer of basal cells that touch the dermis. Taking mice as an example, epithelial cells derived from neonates (or fetuses) can be preferably used as epithelial cells, but even cells derived from mature skin, for example, the epidermis of resting hair or the growing hair It may also be a culture of cells in the form of keratinocytes. Such cells can be prepared from the skin of the desired donor animal by methods well known to those skilled in the art.
好適な態様において、上皮系細胞は以下のとおりにして調製できる。
1.哺乳動物の表皮を用意する。
2.この表皮を、必要なら0.25%トリプシン/PBS中で4℃下で一晩静置することでトリプシン処理する。
3.ピンセットなどにより表皮部分のみ剥離し、細切後、適当な培養液(例えばケラチノサイト用培養液)中で4℃で約1時間懸濁処理する。
4.この懸濁物を適当なポアサイズを持つセルストレーナーに通し、次いで遠心分離器にかけて上皮系細胞を回収する。
5.この細胞調製品をKGMあるいはSFM培地に所望の細胞密度で懸濁し、使用直前まで氷上に静置しておく。
In a preferred embodiment, epithelial cells can be prepared as follows.
1. Prepare a mammalian epidermis.
2. The epidermis is trypsinized by standing overnight at 4 ° C. in 0.25% trypsin / PBS if necessary.
3. Only the epidermis is peeled off with tweezers, etc., and after chopping, suspended in an appropriate culture solution (for example, a culture solution for keratinocytes) at 4 ° C. for about 1 hour.
4). The suspension is passed through a cell strainer with an appropriate pore size and then centrifuged to collect epithelial cells.
5. This cell preparation is suspended in KGM or SFM medium at a desired cell density and allowed to stand on ice until just before use.
本発明の上皮系細胞は毛乳頭細胞と同様、あらゆる哺乳動物、例えばヒト、チンパンジー、その他の霊長類、家畜動物、例えばイヌ、ネコ、ウサギ、ウマ、ヒツジ、ヤギ、ウシ、ブタ、他に実験用動物、例えばラット、マウス、モルモット、より好ましくはヌードマウス、スキッドマウス、ヌードラットの表皮に由来し得る。また、その表皮部位は有毛部位、例えば頭皮でも、無毛部位、例えば包皮であってもよい。 The epithelial cells of the present invention can be tested in any mammal, for example, humans, chimpanzees, other primates, livestock animals such as dogs, cats, rabbits, horses, sheep, goats, cows, pigs, etc. It can be derived from the epidermis of a working animal such as a rat, mouse, guinea pig, more preferably nude mouse, skid mouse, nude rat. Further, the epidermis part may be a hairy part, for example, a scalp, or a hairless part, for example, a foreskin.
本発明者は、上記凍結保存により獲得した、活性細胞として毛乳頭細胞のみを含有し、上皮系細胞の死滅した毛乳頭細胞調製品を、毛乳頭細胞の除かれた活性上皮系細胞のみを含有する上皮系細胞調製品と様々な細胞比率で混合し、レシピエント動物に移植して毛包の再生を検討したところ、毛乳頭細胞、対、上皮系細胞の細胞数の比と毛包の再生との間で一定の関係があることが見出された。即ち、毛包をより多く再生させることが所望される場合、活性毛乳頭細胞、対、活性上皮系細胞の細胞数の比を1:3〜10:1、更に好ましくは1:1〜10:1、更により好ましくは1:1〜3:1、最も好ましくは1:1とすべきことが見出された。換言すれば、活性毛乳頭細胞と活性上皮系細胞の比率を適宜調整してレシピエント動物に移植すれば、毛包の再生を調整できる。 The present inventor obtained only the dermal papilla cells as active cells, obtained by the above cryopreservation, and contained the dermal papilla cell preparation in which the epithelial cells were killed, and only the active epithelial cells from which the dermal papilla cells were removed. The epithelial cell preparations were mixed at various cell ratios and transplanted into recipient animals to study hair follicle regeneration. It has been found that there is a certain relationship between That is, when it is desired to regenerate more hair follicles, the ratio of the number of active hair papilla cells to active epithelial cells is 1: 3 to 10: 1, more preferably 1: 1 to 10: It has been found that it should be 1, even more preferably 1: 1 to 3: 1, most preferably 1: 1. In other words, hair follicle regeneration can be adjusted by appropriately adjusting the ratio of active hair papilla cells and active epithelial cells and transplanting the cells into a recipient animal.
毛乳頭細胞と上皮系細胞との組み合わせは同種系でも、異種系でもよい。例えば、毛乳頭細胞調製品がマウスに由来する場合、上皮系細胞はマウスに由来するか(同種系)、又はその他の種、例えばラット、ヒトに由来してもよい(異種系)。従って、本発明の毛包を再生するための組成物は、例えば、毛乳頭細胞及び上皮系細胞が共にマウスに由来する組み合わせ、共にラットに由来する組み合わせ、もしくは共にヒトに由来する組み合わせでも(以上、同種)、又は毛乳頭細胞がマウスに由来し、上皮系細胞がラットに由来する組み合わせ、毛乳頭細胞がラットに由来し、上皮系細胞がマウスに由来する組み合わせ、毛乳頭細胞がマウスに由来し、上皮系細胞がヒトに由来する組み合わせ、毛乳頭細胞がラットに由来し、上皮系細胞がヒトに由来する組み合わせ、毛乳頭細胞がヒトに由来し、上皮系細胞がマウスに由来する組み合わせ、毛乳頭細胞がヒトに由来し、上皮系細胞がラットに由来する組み合わせ(以上、異種)、等であってよい。 The combination of dermal papilla cells and epithelial cells may be the same or different. For example, when the dermal papilla cell preparation is derived from a mouse, the epithelial cells may be derived from a mouse (homogeneous) or from other species such as rats, humans (heterologous). Therefore, the composition for regenerating the hair follicle of the present invention may be, for example, a combination in which the dermal papilla cells and epithelial cells are both derived from a mouse, a combination that is both derived from a rat, or a combination that is both derived from a human. Allogeneic), or hair papilla cells derived from mice, epithelial cells derived from rats, hair papilla cells derived from rats, epithelial cells derived from mice, hair papilla cells derived from mice A combination in which epithelial cells are derived from human, a hair papilla cell is derived from rat, a combination in which epithelial cells are derived from human, a combination in which hair papilla cells are derived from human, and an epithelial cell is derived from mouse, A combination of the hair papilla cells derived from a human and the epithelial cells derived from a rat (hereinafter, different types) may be used.
本発明に係る毛包の再生のための組成物をレシピエント動物に移殖する方法は、それ自体公知の移殖方法によることができる。例えば、Weinberg et al, J. Invest. Dermatol. Vol.100(1993), pp.229-236を参照のこと。例えばヌードマウスに移植を行う場合、用意された細胞を移植直前〜1時間前に混合し、遠心(9000×g,10min.)により培養液を取り除き、50〜100μL程度の細胞塊にした後、すみやかにヌードマウス背部皮膚に埋め込んだシリコン製のドーム型チャンバー内に流し込む。1週間後にチャンバーを注意深く取りはずし、さらに2週間目以降に移植部位の毛髪形成の有無の肉眼観察を行うことができる。ヒトを含む動物に発毛を目的に移植を行う場合も似たようにして行うことができ、適切な方法は医師や獣医により適宜決定されるであろう。
移植は、例えば直径約1cmの円に対し、毛乳頭細胞が1×106〜108個/cm2、好ましくは1.0〜1.5×107個/cm2の移植量、より好ましくは1.27×107個/cm2の移植量で移植されるように行うのが好ましい。
The method for transferring the composition for regrowth of the hair follicle according to the present invention to a recipient animal may be a transfer method known per se. See, for example, Weinberg et al, J. Invest. Dermatol. Vol. 100 (1993), pp. 229-236. For example, when transplanting into nude mice, the prepared cells are mixed immediately before transplantation to 1 hour before transplantation, and the culture solution is removed by centrifugation (9000 × g, 10 min.) To make a cell mass of about 50 to 100 μL. Immediately pour into a silicon dome-shaped chamber embedded in the back of a nude mouse. After one week, the chamber is carefully removed, and after the second week, the presence or absence of hair formation at the transplanted site can be visually observed. A similar method can be used for transplantation for hair growth in animals including humans, and an appropriate method will be appropriately determined by a doctor or veterinarian.
For transplantation, for example, with respect to a circle having a diameter of about 1 cm, the amount of hair papilla cells transplanted is 1 × 10 6 to 10 8 cells / cm 2 , preferably 1.0 to 1.5 × 10 7 cells / cm 2 , more preferably. Is preferably transplanted at a transplantation rate of 1.27 × 10 7 cells / cm 2 .
上記組成物をレシピエント動物に移植する場合、その移植は同種移植、即ち自己移植、同種同系移植もしくは同種異系移植であっても、異種移植であってもよい。同種移植の場合、毛乳頭細胞調製品及び上皮系細胞は共にレシピエントと同種である。異種移植では、毛乳頭細胞調製品又は上皮系細胞のいずれか一方がレシピエントと異種であり、他方がレシピエントと同種である場合と、双方がレシピエントと異種の場合がある。レシピエント動物としてはあらゆる哺乳動物、例えばヒト、チンパンジー、その他の霊長類、家畜動物、例えばイヌ、ネコ、ウサギ、ウマ、ヒツジ、ヤギ、ウシ、ブタ、他に実験用動物、例えばラット、マウス、モルモット、より好ましくはヌードマウス、スキッドマウス、ヌードラットが挙げられる。 When the composition is transplanted into a recipient animal, the transplant may be an allograft, that is, an autograft, an allogeneic transplant, an allogeneic transplant, or a xenotransplant. In the case of allogeneic transplantation, the dermal papilla cell preparation and epithelial cells are both allogeneic with the recipient. In xenotransplantation, either the dermal papilla cell preparation or the epithelial cells may be xenogeneic with the recipient and the other may be xenogeneic with the recipient, or both may be xenogeneic with the recipient. Recipient animals include any mammals such as humans, chimpanzees, other primates, livestock animals such as dogs, cats, rabbits, horses, sheep, goats, cows, pigs, and other laboratory animals such as rats, mice, Guinea pigs, more preferably nude mice, skid mice and nude rats are mentioned.
また、本発明に係る上記組成物を適当なレシピエント動物に移植することで、再生毛包を担持するキメラ動物を提供することができる。かかるキメラ動物は、例えば毛包の再生の機構を研究・解明するため、あるいは毛包再生又は発毛もしくは脱毛に有効な薬剤・生薬のスクリーニングを行うための有力な動物モデルを担うことができるであろう。レシピエント動物は、該動物に移植される系に含まれる各細胞の起源に拘わりなく、免疫系が抑制された動物であることが好ましい。また動物種としては、実験動物として使用しうるものであり、本発明の目的に沿うものである限り、いかなる動物であってもよいが、好ましくは、マウス、ラット等を挙げることができる。このような動物のうち、免疫系が抑制されているものとしては、マウスを例にすれば、ヌードマウスのように、胸腺欠損のごとき形質をもつものが挙げられる。なお、本発明の目的を考慮すれば、特に好ましいレシピエント動物としては、市販のヌードマウス(例えば、Balb−c nu/nu系統)、スキッドマウス(例えば、Balb/c−SCID)、ヌードラット(例えば、F344/N Jcl−rnu)を挙げることができる。 In addition, a chimeric animal carrying a regenerated hair follicle can be provided by transplanting the composition according to the present invention to a suitable recipient animal. Such a chimeric animal can serve as an influential animal model, for example, to study and elucidate the mechanism of hair follicle regeneration, or to screen for drugs / herbicides effective for hair follicle regeneration or hair growth or hair loss. I will. The recipient animal is preferably an animal with a suppressed immune system, regardless of the origin of each cell contained in the system to be transplanted into the animal. The animal species may be any animal as long as it can be used as an experimental animal and meets the purpose of the present invention, and preferred examples include mice and rats. Among such animals, those whose immune system is suppressed include those having traits such as athymic deficiency, such as nude mice, in the case of mice. In view of the object of the present invention, particularly preferable recipient animals include commercially available nude mice (for example, Balb-c nu / nu strain), skid mice (for example, Balb / c-SCID), nude rats ( For example, F344 / N Jcl-rnu) can be mentioned.
更に、本発明に係る組成物を三次元皮膚モデルに含包させることで、再生毛包を担持する三次元皮膚モデルを提供することができる。三次元皮膚モデルは当業者周知の方法(Exp.Cell Res. Amano S. et al., (2001), Vol.271, pp.249-262)により、例えば下記のようにして作製することができる。三次元皮膚モデルは毛乳頭細胞を1×106〜108個/cm2、好ましくは1.0〜1.5×107個/cm2、より好ましくは約1.27×107個/cm2の量で含む。 Furthermore, a 3D skin model carrying a regenerated hair follicle can be provided by including the composition according to the present invention in a 3D skin model. The three-dimensional skin model can be prepared by a method well known to those skilled in the art (Exp.Cell Res. Amano S. et al., (2001), Vol.271, pp.249-262), for example, as follows. . The three-dimensional skin model has 1 × 10 6 to 10 8 cells / cm 2 , preferably 1.0 to 1.5 × 10 7 cells / cm 2 , more preferably about 1.27 × 10 7 cells / cm 2 . in an amount of cm 2.
三次元皮膚モデル作製方法
ヒト線維芽細胞を0.1%コラーゲン溶液/DMEM/10%FBSに適当量分散させ、シャーレに分注し、ただちに37℃のCO2インキュベータに静置する。ゲル化後、シャーレ壁面および底面よりゲルを剥がし、シャーレの中で浮遊するようにさせる。コラーゲンゲルを揺らせながら培養し、ゲルを約5分の1に収縮させ真皮モデルとする。真皮モデルをステンレスグリッドの上に置き、その上にガラスリングをセットし、KGM(表皮細胞培養用培地)に分散したヒト培養表皮細胞(1.0X106 細胞数/ml)を0.4ml、ガラスリング内に注入し、培養する。このとき、毛乳頭細胞画分を同時に混合して注入する。ヒト培養表皮細胞の代替としてマウス新生児表皮細胞を用いることもできる。シャーレ内にDMEM―KGM―5%FBS+Ca2+の培地を、真皮モデルの上部が空気に晒される程度に入れ、培養し、約一週間後に皮膚モデルを観察し、毛包原基形成の有無と再現性を判定する。
Method for preparing three-dimensional skin model Human fibroblasts are dispersed in an appropriate amount in 0.1% collagen solution / DMEM / 10% FBS, dispensed into a petri dish, and immediately left in a CO 2 incubator at 37 ° C. After gelation, the gel is peeled off from the petri dish wall and bottom surface so that it floats in the petri dish. The collagen gel is cultured while being shaken, and the gel is contracted to about 1/5 to obtain a dermis model. Place the dermis model on a stainless steel grid, set a glass ring on it, 0.4 ml of human cultured epidermal cells (1.0 × 10 6 cells / ml) dispersed in KGM (epidermal cell culture medium), glass Inject into the ring and incubate. At this time, the hair papilla cell fraction is mixed and injected at the same time. As an alternative to human cultured epidermal cells, mouse neonatal epidermal cells can also be used. Place the medium of DMEM-KGM-5% FBS + Ca 2+ in the petri dish so that the upper part of the dermis model is exposed to the air, and observe the skin model after about one week. Determine reproducibility.
再構成毛包を担持した3次元皮膚モデルは、上記再生毛包を担持するキメラ動物と同様、毛包の再生の機構を研究・解明や発毛・脱毛に有効な薬剤・生薬のスクリーニングに利用できる。 The three-dimensional skin model carrying reconstituted hair follicles is used for research and elucidation of the mechanism of hair follicle regeneration, as well as for the screening of drugs and herbal medicines that are effective for hair growth and hair removal, similar to the chimeric animal carrying the regenerated hair follicles. it can.
以下に実施例を挙げて本発明をさらに詳細に説明する。 Hereinafter, the present invention will be described in more detail with reference to examples.
真皮細胞画分の凍結保存により、上皮細胞が死滅し、活性細胞として毛乳頭細胞のみを含有する細胞調製品が得られることを確認するため、バーシカン(Versican)プロモーター下流にマーカータンパク、LacZ、の構造遺伝子をつないだ発現ベクターを導入したトランスジェニックマウス(以下「バーシカン−LacZ TGマウス」)より採取した皮膚組織より得られた細胞画分を凍結保存し、融解した細胞調製品についてフローサイトメトリー解析した。 In order to confirm that cryopreservation of the dermal cell fraction kills epithelial cells and obtains a cell preparation containing only dermal papilla cells as active cells, the marker protein LacZ, downstream of the Versican promoter Flow cytometric analysis of cell preparations obtained by cryopreserving cell fractions obtained from skin tissue collected from transgenic mice (hereinafter referred to as “Versican-LacZ TG mice”) into which an expression vector linked with a structural gene has been introduced. did.
(1)バーシカン−LacZ TGマウスの真皮細胞からの「凍結保存」毛乳頭細胞調製品の調製
(1−1) バーシカン−LacZ TGマウスから生まれた新生仔(生後4日以内に使用)のうち、LacZ陽性の個体を選別した。バーシカン−LacZ TGマウスは、例えばKishimotoら(前掲)に記載の方法により作製することができる。
(1−2) 各個体をエタノールとリン酸緩衝生理食塩水(以下「PBS」)で洗浄後、背部皮膚を剥離し、0.25%トリプシン/PBS中で4℃下で一晩静置した。
(1−3) 翌日、ピンセットなどにより表皮と真皮を分離し、真皮側を0.35%コラゲナーゼ/DMEM(ダルベッコ変法イーグル最少培地。以下「DMEM」)により37℃下で約1時間ほど処理した。
(1−4) (1−3)の細胞を念入りに懸濁操作を行ったのち、セルストレーナーに通し、次いで遠心分離器(900g、10分)によって細胞を集めた。
(1−5) 細胞数を計測し、1x105〜 1x108/mlの細胞密度にて細胞凍結保護液(セルバンカ−2(BLC−2)、日本全薬工業製)で再懸濁し、凍結チューブに分注、通常の細胞保存方法に従い、液体窒素内で保存した。
(1−6) 約1週間後に融解し、これを以下のフローサイトメトリー解析に用いた。
(1) Preparation of “cryopreserved” hair papilla cell preparation from dermal cells of Versican-LacZ TG mice (1-1) Among newborns born from Versican-LacZ TG mice (used within 4 days of birth) LacZ positive individuals were selected. Versican-LacZ TG mice can be prepared, for example, by the method described in Kishimoto et al.
(1-2) After washing each individual with ethanol and phosphate buffered saline (hereinafter “PBS”), the dorsal skin was peeled off and allowed to stand overnight at 4 ° C. in 0.25% trypsin / PBS. .
(1-3) The next day, the epidermis and dermis are separated with tweezers, etc., and the dermis side is treated with 0.35% collagenase / DMEM (Dulbecco's modified Eagle's minimal medium; hereinafter “DMEM”) at 37 ° C. for about 1 hour. did.
(1-4) After carefully suspending the cells of (1-3), the cells were passed through a cell strainer and then collected by a centrifuge (900 g, 10 minutes).
(1-5) Count the number of cells, resuspend in a cell cryoprotectant (Selvanka-2 (BLC-2), manufactured by Nippon Zenyaku Kogyo) at a cell density of 1 × 10 5 to 1 × 10 8 / ml, and freeze tube In accordance with a normal cell storage method, the cells were stored in liquid nitrogen.
(1-6) Thawed after about one week, and used for the following flow cytometry analysis.
(2)フルオロレポーター LacZフローサイトメトリー解析
実験材料
・フルオロレポーター LacZフローサイトメトリーキット(FluoroReporter lacZ flow cytometry kits) Molecular Probe社、カタログNo.F-1930(50反応分)/F-1931(250反応分))
・試薬の準備:
反応液:キット中のFDG試薬(Component A)をMiliQ水で1:10に希釈した。1サンプル当り50μLを使用した。
停止液:キット中のPI試薬(Component D)をキット付属の緩衝液で1:100に希釈した。1サンプル当り0.9mlを使用した。使用するまで氷中において4℃に冷やしておいた。染色媒体としては、上皮細胞を特異的に染色する特的抗体であるCD49fモノクローナル抗体(セロテック社製、MCA699)、死細胞を特異的に染色する7-ADD(ベックマンコールター製、PN-IM 3422)を用いた。
(2) Fluororeporter LacZ flow cytometry analysis materials / Fluororeporter LacZ flow cytometry kits Molecular Probe, Catalog No. F-1930 (for 50 reactions) / F-1931 (for 250 reactions))
・ Reagent preparation:
Reaction solution: FDG reagent (Component A) in the kit was diluted 1:10 with MiliQ water. 50 μL was used per sample.
Stop solution: The PI reagent (Component D) in the kit was diluted 1: 100 with the buffer supplied with the kit. 0.9 ml was used per sample. It was chilled to 4 ° C. in ice until use. As a staining medium, a CD49f monoclonal antibody (manufactured by Cellotech, MCA699), which is a specific antibody that specifically stains epithelial cells, and 7-ADD (manufactured by Beckman Coulter, PN-IM 3422) that specifically stains dead cells Was used.
(2−1) バーシカン−LacZ TGマウス由来の真皮細胞の懸濁液を〜1x107細胞数までの細胞数に調整して、750ulの染色媒体を加えて、1.5mlのエッペンチューブに移した。
(2−2) 3000回転で5分間遠心し、上澄みを捨てた。細胞ペレットを100μLの染色媒体に再懸濁した。この懸濁物を37℃の恒温槽で10分間プレインキュベーションした。
(2−3) 37℃の恒温槽で10分間プレインキュベーションしておいた反応液を50μL加えて、正確に1分間、37℃で反応を行った。
(2−4) 0.9ml の停止液を加え、氷中に保存した。
(2−5) 10分後に40μLの50mM PETG(Component B)を加えて反応を完全に阻害した。
(2−6) すみやかにFACSで蛍光強度を測定した。フローサイトメーター(FACS)の操作方法はメーカーの取扱説明書によった。FACSの測定装置は例えば、ベックマン・コールター社のXL−MCLを用いることができる。本キットに使用されている蛍光色素Fluorescein(フルオロセイン)に適した検出設定で細胞の蛍光強度の分布を測定した。
(2-1) A suspension of dermal cells derived from versican-LacZ TG mice was adjusted to a cell number of up to ˜1 × 10 7 cells, 750 ul of staining medium was added, and the suspension was transferred to a 1.5 ml Eppendorf tube.
(2-2) The mixture was centrifuged at 3000 rpm for 5 minutes, and the supernatant was discarded. The cell pellet was resuspended in 100 μL staining media. This suspension was preincubated for 10 minutes in a 37 ° C. thermostat.
(2-3) 50 μL of a reaction solution preincubated for 10 minutes in a 37 ° C. constant temperature bath was added, and the reaction was performed at 37 ° C. for exactly 1 minute.
(2-4) 0.9 ml of stop solution was added and stored in ice.
(2-5) After 10 minutes, 40 μL of 50 mM PETG (Component B) was added to completely inhibit the reaction.
(2-6) The fluorescence intensity was immediately measured by FACS. The operation method of the flow cytometer (FACS) was according to the manufacturer's instruction manual. As the FACS measuring apparatus, for example, XL-MCL manufactured by Beckman Coulter can be used. The distribution of the fluorescence intensity of the cells was measured with a detection setting suitable for the fluorescent dye Fluorescein used in this kit.
(3)解析結果
LacZ及び7-AADに基づくFACS解析は、凍結融解した細胞中のLacZ+細胞の大半が、凍結融解を経ても生細胞であることを示した(図1)。従って、毛乳頭細胞は凍結融解によって死滅しないこと明らかとなった。また、CD-49及び7-AADに基づくFACS解析では、CD-49+細胞(上皮系細胞)の大半が凍結融解後、7-AAD+画分(死画分)に存在することが示された(図2)。従って、凍結融解した細胞調製品中の生細胞はLacZ+、CD-49-、7-AAD-、即ち、毛乳頭細胞(LacZ+)且つ非上皮系細胞(CD-49-)であり、しかも生細胞(7-AAD-)である。以上の結果をまとめると、生細胞は大半が上皮系細胞ではなく、毛乳頭細胞であることが明らかとなった。よって、凍結融解により上皮系細胞を特異的に死滅させることができ、活性細胞として毛乳頭細胞のみ含む毛乳頭細胞調製品を調製できることが明らかとなった。
(3) Analysis results
FACS analysis based on LacZ and 7-AAD showed that the majority of LacZ + cells in freeze-thawed cells were viable cells even after freezing and thawing (FIG. 1). Therefore, it became clear that the hair papilla cells were not killed by freezing and thawing. In addition, FACS analysis based on CD-49 and 7-AAD shows that most of CD-49 + cells (epithelial cells) are present in the 7-AAD + fraction (dead fraction) after freezing and thawing. (FIG. 2). Therefore, the living cells in the frozen and thawed cell preparation are LacZ + , CD-49 − , 7-AAD − , ie, hair papilla cells (LacZ + ) and non-epithelial cells (CD-49 − ), a - living cells (7-AAD). Summarizing the above results, it was found that most of the living cells were not epithelial cells but dermal papilla cells. Thus, it was revealed that epithelial cells can be specifically killed by freezing and thawing, and a hair papilla cell preparation containing only hair papilla cells as active cells can be prepared.
凍結融解毛乳頭細胞と上皮系細胞の混合移植により毛包再生を試みた。
I.各種細胞の調製
(1)マウス由来上皮細胞
(1−1) 手術前日、ICR系統マウスの新生仔より各個体をエタノールとリン酸緩衝生理食塩水(以下「PBS」)で洗浄後、背部皮膚を剥離し、0.25%トリプシン/PBS中で4℃下で一晩静置することで皮膚をトリプシン処理した。
(1−2) ピンセットにより表皮部分のみ剥離し、細切後、ケラチノサイト用培養液(以下「KGM」)中で4℃で約1時間懸濁処理した。
(1−3) セルストレーナーに通した(1−2)の懸濁物を遠心分離器(×900g、10分)にかけて上皮系細胞を回収した。
(1−4) レシピエント動物1個体あたり、2匹の新生仔由来に相当する量の上皮系細胞(細胞数として約1x107)を手術に用いた。相当量の細胞をKGMあるいはSFM培地で懸濁して、使用直前まで氷上に静置した。これを「マウス由来上皮細胞」調製品とする。
We tried to regenerate hair follicles by mixed transplantation of frozen and thawed dermal papilla cells and epithelial cells.
I. Preparation of various cells (1) Mouse-derived epithelial cells (1-1) The day before surgery, each individual was washed from a newborn ICR mouse with ethanol and phosphate buffered saline (hereinafter “PBS”), and the back skin was removed. The skin was trypsinized by exfoliation and standing overnight at 4 ° C. in 0.25% trypsin / PBS.
(1-2) Only the epidermis part was peeled off with tweezers, and after chopping, suspension treatment was performed at 4 ° C. for about 1 hour in a culture solution for keratinocytes (hereinafter “KGM”).
(1-3) The suspension of (1-2) passed through a cell strainer was subjected to a centrifuge (× 900 g, 10 minutes) to recover epithelial cells.
(1-4) An amount of epithelial cells (about 1 × 10 7 as the number of cells) corresponding to two newborns was used for surgery per recipient animal. A considerable amount of cells were suspended in KGM or SFM medium and left on ice until just before use. This is a “mouse-derived epithelial cell” preparation.
(2)「用時調製」マウス由来真皮細胞調製品(比較例)の調製
(2−1) 手術前日、ICR系統マウスの新生仔より上記(1−1)、(1−2)と同様の方法により皮膚をトリプシン処理した。
(2−2) ピンセットにより表皮部分を剥離し、残った真皮を細切後、0.35%のコラゲナーゼを含んだ適当な培養液DMEM+10%FBS中で37℃で約1時間懸濁処理した。
(2−3) セルストレーナーに通した懸濁物(2−2)を遠心分離器にかけて真皮細胞を回収した。
(2−4) レシピエント動物1個体あたり、細胞数として約1x107の真皮細胞を手術に用いた。相当量の細胞をDMEM+10%FBSなどで懸濁して、使用直前まで氷上に静置した。これを「用時調製」マウス由来真皮細胞調製品とする。
(2) Preparation of “prepared in use” mouse-derived dermal cell preparation (comparative example) (2-1) Same day as above (1-1) and (1-2) from the day before surgery, from newborn ICR mouse strain The skin was trypsinized by the method.
(2-2) The epidermis part was peeled off with tweezers, and the remaining dermis was cut into small pieces and then suspended in an appropriate culture solution DMEM + 10% FBS containing 0.35% collagenase at 37 ° C. for about 1 hour.
(2-3) Dermal cells were collected by centrifuging the suspension (2-2) passed through the cell strainer.
(2-4) About 1 × 10 7 dermal cells were used for surgery per recipient animal. A considerable amount of cells were suspended in DMEM + 10% FBS or the like and left on ice until just before use. This is a “prepared at the time of use” mouse-derived dermal cell preparation.
(3)毛乳頭細胞画分を含む「凍結保存」マウス由来真皮細胞調製品の調製
(3−1) 新生仔ICR系統マウス背部皮膚を剥離し、表皮を採取した。
(3−2) トリプシン溶液で一晩静置し、翌日表皮をピンセットで取り除き、残った真皮をコラゲナーゼで処理、細胞懸濁液を調製した。
(3−3) セルストレーナーにより上記懸濁物をろ過し、そして静置により沈殿物を除去した。
(3−4) 細胞数を計測し、1x105〜 1x108/mlの細胞密度に凍結保護液で再懸濁し、凍結チューブに分注、通常の細胞保存方法に従い、液体窒素内で保存した。
(3−5) 約1週間後に融解し、移植実験に1x107個/移植を用いた。これを「凍結保存」マウス由来真皮細胞調製品とする。
(3) Preparation of “cryopreserved” mouse-derived dermis cell preparation containing hair follicle cell fraction (3-1) Newborn ICR strain mouse dorsal skin was peeled and epidermis was collected.
(3-2) The plate was allowed to stand overnight in a trypsin solution, and the epidermis was removed with tweezers the next day, and the remaining dermis was treated with collagenase to prepare a cell suspension.
(3-3) The suspension was filtered with a cell strainer, and the precipitate was removed by standing.
(3-4) The number of cells was counted, resuspended in a cryoprotective solution at a cell density of 1 × 10 5 to 1 × 10 8 / ml, dispensed into a freezing tube, and stored in liquid nitrogen according to a normal cell storage method.
(3-5) Thawed after about 1 week, and 1 × 10 7 cells / transplant were used for transplantation experiments. This is a “cryopreserved” mouse-derived dermal cell preparation.
II.毛包再構成方法(動物への移植方法)
上記マウス由来上皮細胞調製品(1−4)を「用時調製」マウス由来真皮細胞調製品(2−4)又は「凍結保存」マウス由来真皮細胞調製品(3−5)と混合した。これらの混合物を以下の「再構成毛包作成手順」の「細胞懸濁液」として用いた。
II. Hair follicle reconstruction method (implantation method to animals)
The mouse-derived epithelial cell preparation (1-4) was mixed with “prepared when used” mouse-derived dermal cell preparation (2-4) or “cryopreserved” mouse-derived dermal cell preparation (3-5). These mixtures were used as “cell suspension” in the following “reconstruction hair follicle preparation procedure”.
<再構成毛包作成手順>
用意するもの:
レシピエント動物(Balb−c nu/un系統ヌードマウス。5週齢以上)、
シリコーン製の直径1センチ程度のドーム状キャップ(以下バルブと呼称)、
麻酔薬、
手術用ハサミ、ピンセット、縫合器、
マイクロピペッター
細胞懸濁液(培養液DMEM+10%FBS約150μlに懸濁)
<Reconstruction hair follicle creation procedure>
Things to prepare:
Recipient animals (Balb-c nu / un strain nude mice, 5 weeks of age or older),
Silicone dome-shaped cap with a diameter of about 1 cm (hereinafter referred to as “bulb”),
Anesthetic,
Surgical scissors, tweezers, suture device,
Micropipetter Cell suspension (suspended in about 150 μl of culture medium DMEM + 10% FBS)
<手順>
(i) ヌードマウスを麻酔した。
(ii) 背部皮膚を直径1センチ弱に切り取った。
(iii)傷口にバルブを挿入し、縫合器で固定した。
(iv) バルブ内に、細胞懸濁液をピペッターを用いて注入した。
(v) そのまま約1週間飼育し、バルブをはずした。
(vi) バルブをはずした後、1〜6週間後(通常は2週間後)、かさぶたが取れた跡に、再構成毛包の生育を観察した。
<Procedure>
(I) Nude mice were anesthetized.
(Ii) The back skin was cut to a diameter of less than 1 cm.
(Iii) A valve was inserted into the wound and fixed with a suture instrument.
(Iv) The cell suspension was injected into the valve using a pipettor.
(V) They were kept for about a week and the valve was removed.
(Vi) After removing the bulb, the growth of the reconstructed hair follicle was observed after 1-6 weeks (usually after 2 weeks), after the scab was removed.
毛包再構成実験の結果を以下の表1及び図3に示す。「用時調製」マウス由来真皮細胞調製品のみを移植した場合でも毛包再生が認められるのに対し、「凍結保存」マウス由来真皮細胞調製品のみを移植した場合には毛包再生は認められなかった。この結果は、Kishimotoら(前掲)のトランスジェニックマウス由来の真皮細胞画分からセルソーターにより純化した毛乳頭細胞を用いて得られた結果と一致し、「凍結保存」マウス由来真皮細胞調製品には活性細胞成分として毛乳頭細胞のみが含まれていることを実証した。
毛乳頭細胞画分と上皮系細胞画分の細胞比率の毛包再構成効率に及ぼす影響
「凍結保存」マウス由来真皮細胞調製品と、実施例2記載のマウス由来上皮細胞と同様の処理により調製したラット新生児皮膚由来上皮系細胞とをそれぞれ、0、 1x106 、3×106、1x107の細胞数に調整し、混合し、上述の再構成毛包作成手順によりヌードマウス背部皮膚に移植して毛包再構成の有無を調べた。その結果を以下の表2に示す。
Effect of cell ratio of dermal papilla cell fraction and epithelial cell fraction on hair follicle reconstitution efficiency Prepared by treatment similar to that of "cryopreserved" mouse-derived dermal cell preparation and mouse-derived epithelial cells described in Example 2 The rat neonatal skin-derived epithelial cells were adjusted to 0, 1 × 10 6 , 3 × 10 6 , and 1 × 10 7 cells, mixed, and transplanted to the back skin of nude mice according to the above-described reconstructed hair follicle preparation procedure. The presence or absence of hair follicle reconstruction was examined. The results are shown in Table 2 below.
表2の結果から、毛乳頭細胞と上皮系細胞との混合比が1:10〜10:1の範囲において毛包の再生が認められ、1:1〜3:1、特に1:1程度の細胞混合物を移植したとき、毛包の再生が顕著に生ずることがわかった。 From the results of Table 2, hair follicle regeneration was observed when the mixing ratio of dermal papilla cells and epithelial cells was in the range of 1:10 to 10: 1, and 1: 1 to 3: 1, particularly about 1: 1. It has been found that hair follicle regeneration occurs markedly when the cell mixture is implanted.
上皮系細胞を成熟したマウス皮膚由来とした場合の毛包再構成
成熟したマウス皮膚由来(10週齢以降)の上皮系細胞の調製を、実施例2に記載の新生児マウス由来上皮系細胞の調製に準じて行った。成熟マウス皮膚由来の上皮系細胞として、生後10週齢以降のマウスの休止期毛の表皮から調製したもの(休止期毛上皮系細胞含有系)と、休止期毛の皮膚をワックス塗布による除毛処理により機械的刺激し、発毛を促したマウスの表皮から調製したもの(成長期誘導毛上皮系細胞含有系)の二種類を用いた。これら成熟マウス皮膚由来上皮系細胞をそれぞれ「凍結保存」マウス由来真皮細胞調製品と細胞数が1:1となるように混合し、上述の再構成毛包作成手順によりマウスの背部に移植した。その結果を以下の表3に示す。
Reconstruction of hair follicles when epithelial cells are derived from mature mouse skin Preparation of epithelial cells derived from mature mouse skin (after 10 weeks of age) It went according to. Epidermal cells derived from mature mouse skin prepared from the resting hair epidermis of mice after 10 weeks of age (containing a resting hair epithelial cell-containing system) and hair removal by applying wax on resting hair skin Two types prepared from the epidermis of mice that were mechanically stimulated by treatment to promote hair growth (growth-phase-induced hair epithelial cell-containing system) were used. These mature mouse skin-derived epithelial cells were mixed with a “cryopreserved” mouse-derived dermal cell preparation so that the cell number was 1: 1, and transplanted to the back of the mouse by the above-described reconstructed hair follicle preparation procedure. The results are shown in Table 3 below.
毛包原基の形成の有無は移植部組織より薄切片を作製し、ヘマトキシリン−エオジン染色などの一般染色後、形態観察により表皮層の陥没と真皮線維芽細胞の表皮陥没部直下における凝集により判定した。 The presence or absence of hair follicle primordium is determined by preparing a thin section from the transplanted tissue, and after general staining such as hematoxylin-eosin staining, by morphological observation, by the depression of the epidermis layer and the aggregation of the dermal fibroblasts directly under the epidermis did.
この結果から明らかな通り、休止期毛上皮系細胞含有系、成長期誘導毛上皮系細胞含有系のいずれを移植した場合でも、発毛が認められた。従って、上皮系細胞は新生仔表皮に限らず、成熟表皮、例えば休止期毛又は成長期毛の表皮に由来する場合でも、毛包再生に有効であることがわかった。 As is apparent from these results, hair growth was observed when either the resting hair epithelial cell-containing system or the growth-phase induced hair epithelial cell-containing system was transplanted. Therefore, it was found that epithelial cells are effective for hair follicle regeneration not only in the neonatal epidermis but also in the mature epidermis, for example, the epidermis of resting or growing hair.
毛乳頭細胞と上皮系細胞とを異種系にした場合の毛包再構成
「凍結保存」マウス由来真皮細胞調製品とラット新生児皮膚由来上皮系細胞とをそれぞれ約1x107個混合し、上述の再構成毛包作成手順によりヌードマウス背部皮膚に移植して毛包再構成の有無を調べた。その結果は以下の表4及び図4にも示す。
Reconstruction of hair follicles when dermal papilla cells and epithelial cells are made heterogeneous. Mix approximately 1 × 10 7 each of “cryopreserved” mouse-derived dermal cell preparations and rat neonatal skin-derived epithelial cells. The hair follicle reconstruction was examined by transplanting it onto the skin of the back of nude mice by the procedure for making the constituent hair follicle. The results are also shown in Table 4 below and FIG.
この結果から明らかなとおり、毛乳頭細胞と上皮系細胞との混合物が異種系であっても、同種系と同様、毛包を再生させるのに有効であることがわかった。 As is apparent from these results, it was found that even if the mixture of dermal papilla cells and epithelial cells is a heterogeneous system, it is effective for regenerating hair follicles, as in the same system.
上皮系細胞をヒト新生児包皮由来とした場合の毛包再構成
割礼などにより得られたヒト新生児包皮より表皮細胞を調製し、凍結保存マウス毛乳頭細胞調製品と混合し、上述の再構成毛包作成手順によりヌードマウス背部皮膚に移植して毛包再構成の有無を調べた。
Reconstruction of hair follicles when epithelial cells are derived from human neonatal foreskin Prepare epidermal cells from human neonatal foreskin obtained by circumcision, mix with cryopreserved mouse hair papilla cell preparation, and reconstruct hair follicles as described above According to the preparation procedure, transplantation was performed on the back skin of nude mice, and the presence or absence of hair follicle reconstruction was examined.
包皮組織は一般的な線維芽細胞培養用培地(DMEM培地など)及び角化細胞培養用培地(ケラチノサイト−SFM培地;インビトロジェンなど)中で冷蔵保存することで、3〜1週間程度、保存することができる。 Foreskin tissue should be stored refrigerated in general fibroblast culture medium (such as DMEM medium) and keratinocyte culture medium (keratinocyte-SFM medium; Invitrogen, etc.) for about 3 to 1 week. Can do.
包皮由来培養細胞は下記の方法により調製した。
上記培地中の包皮組織(人種を問わず利用できる)をPBS(組織培養用、カルシウム、マグネシウムフリー)にストレプトマイシン、ペニシリンなどの抗生物質が添加された溶液で満たされたペトリデッシュ中で30分間、反応させた。さらに10分間、新しいPBSと抗生物質で満たされたペトリデッシュに移し、10分間反応させた。過剰の脂肪組織を除去した後に、約1cm2程度の皮膚片に裁断し、デスパーゼ溶液(合同清酒製:濃度1000U〜5000U)中に浮遊させた状態で4℃、約18時間反応させた。反応後、再びPBS溶液で洗った後に、表皮部分を慎重にピンセットでつまみ剥がした。剥がした表皮シートを5mlの0.05%トリプシン−0.5mMEDTA溶液に懸濁し、37℃で15分間反応させた。
Foreskin-derived cultured cells were prepared by the following method.
Foreskin tissue (available regardless of race) in the above medium for 30 minutes in a Petri dish filled with PBS (for tissue culture, calcium and magnesium free) and added with antibiotics such as streptomycin and penicillin , Reacted. The mixture was further transferred to a Petri dish filled with fresh PBS and antibiotics for 10 minutes and allowed to react for 10 minutes. After removing excess adipose tissue, it was cut into about 1 cm 2 skin pieces and allowed to react at 4 ° C. for about 18 hours while suspended in a despase solution (manufactured by Godo Sake: concentration 1000 U to 5000 U). After the reaction, it was washed again with a PBS solution, and the epidermis portion was carefully removed with tweezers. The peeled skin sheet was suspended in 5 ml of 0.05% trypsin-0.5 mM EDTA solution and reacted at 37 ° C. for 15 minutes.
トリプシンインヒビターを加え、反応を停止した後、900回転で10分間遠心し、上澄みを捨てた。10mlのケラチノサイト−SFM培地(インビトロジェン社製)に再懸濁し、細胞数を計測した。約1x106〜107個の細胞を一回の移植実験に供した。移植のために、継代した培養表皮細胞を調製する場合は、約1x106の表皮細胞をI型ないしはIV型コラーゲン溶液でコートした100mmのシャーレあるいは75cm2一のフラスコに播種し、ケラチノサイト−SFM培地を用いて、CO2インキュベータ内で定法に従い培養を行った。細胞がコンフルエントに達した時点で、トリプシンにより細胞を剥がし、回収し、再度1x106の細胞密度に調整して、必要な細胞数、継代数になるまで培養を続けた。 Trypsin inhibitor was added to stop the reaction, followed by centrifugation at 900 rpm for 10 minutes, and the supernatant was discarded. The cells were resuspended in 10 ml of keratinocyte-SFM medium (Invitrogen) and the number of cells was counted. About 1 × 10 6 to 10 7 cells were subjected to one transplantation experiment. When preparing subcultured cultured epidermal cells for transplantation, about 1 × 10 6 epidermal cells are seeded in a 100 mm petri dish or 75 cm 2 flask coated with type I or type IV collagen solution, and keratinocyte-SFM is seeded. Using the medium, the cells were cultured in a CO 2 incubator according to a conventional method. When the cells reached confluence, they were detached with trypsin, collected, adjusted to a cell density of 1 × 10 6 again, and cultured until the required number of cells and passage number were reached.
上記移植の結果も以下の表5に示す。 The results of the transplantation are also shown in Table 5 below.
上皮系細胞をヒト成人包皮由来とした場合の毛包再構成
包茎除去等の術時に得られた成人包皮組織(20歳代)より表皮細胞を調製し、凍結保存マウス毛乳頭細胞調整品と混合し、上述の再構成毛包作製手順によりヌードマウス背部皮膚に移植して毛包再構成の有無を調べた。
Reconstruction of hair follicle when epithelial cells are derived from human adult foreskin Prepare epidermal cells from adult foreskin tissue (20's) obtained during surgery such as removal of foreskins, and mix with cryopreserved mouse hair papilla cell preparation Then, it was transplanted into the back skin of nude mice by the above-described reconstructed hair follicle preparation procedure, and the presence or absence of hair follicle reconstruction was examined.
成人包皮組織は一般的な線維芽細胞培養用培地(DMEM培地など)及び角化細胞培養培地(ケラチノサイト−SFM培地;インビトロジェン社など)中で冷蔵保存することで、1週間程度保存することができる。 Adult foreskin tissue can be stored for about one week by refrigerated storage in general fibroblast culture medium (such as DMEM medium) and keratinocyte culture medium (keratinocyte-SFM medium; Invitrogen, etc.). .
成人包皮組織由来培養細胞の調製方法は実施例6の新生児包皮由来培養細胞の調製方法に準じて行うことができる。 The preparation method of cultured cells derived from adult foreskin tissue can be performed according to the preparation method of cultured cells derived from neonatal foreskin of Example 6.
上記移植の結果を以下の表6に示す。
この結果から、上皮系細胞として成人ヒト由来のものをマウス毛乳頭と組合わせても毛包の再生に有効であることが判った。このことから、毛包を再生させる系において毛乳頭細胞と組合わせることができる上皮系細胞は、発生過程、成熟した組織に関わらず、利用できることが明らかになった。 From these results, it was found that even epithelial cells derived from adult humans were effective for hair follicle regeneration even in combination with mouse hair papilla. This revealed that epithelial cells that can be combined with dermal papilla cells in a system that regenerates hair follicles can be used regardless of the developmental process and mature tissue.
ヒト包皮由来培養細胞の継代数による毛包再構成に及ぼす影響
実施例6及び7において、ヒト新生児あるいは成人包皮由来の異なる人種の上皮細胞を異なる継代数、培養後にマウス毛乳頭と組合わせて、毛包再構成の実験に供した場合の、再構成の効率について、以下の表7に示す。
この結果から、上皮系細胞として、人種に関わらず、継代数が若いほど、毛包が再構成されることも明らかとなった。 From this result, it became clear that as the epithelial cells, the follicle is reconstructed as the passage number is younger regardless of the race.
再構成された毛包の検討
再構成された毛包が毛乳頭細胞と上皮系細胞との組み合わせにより構成されているかどうかを確認するには、例えば種特異的な抗体を用いる方法や種特異的な遺伝子配列(ヒトAlu配列など)を用いることができる。もっとも簡便には、毛包再生のための本発明に係る組成物として異種系組成物を使用し(例えば毛乳頭細胞をマウス由来とし、上皮系細胞をラット又はヒト由来とする、又はその逆)、核染色に用いられるヘキスト(Hoechst)#33258試薬(Molecular Probe社)による染色によって、異種系のマウスの場合は核内に複数のドット(点)が明瞭に観察されるのに対し、ヒト、ラットではそれが認められないことで容易に組織学的観察により判別することができる(Miller GJ & Ferrara JA、Stain Technol. 63(1):15-21,1988)。
Examination of reconstituted hair follicles To confirm whether reconstituted hair follicles are composed of a combination of dermal papilla cells and epithelial cells, for example, methods using species-specific antibodies or species-specific Gene sequences (such as human Alu sequences) can be used. Most conveniently, a heterogeneous composition is used as a composition according to the present invention for hair follicle regeneration (eg, hair papilla cells are derived from mice and epithelial cells are derived from rats or humans, or vice versa). In the case of a heterologous mouse, a plurality of dots (dots) are clearly observed in a heterogeneous mouse by staining with Hoechst # 33258 reagent (Molecular Probe) used for nuclear staining. Since it is not observed in rats, it can be easily distinguished by histological observation (Miller GJ & Ferrara JA, Stain Technol. 63 (1): 15-21, 1988).
ヘキスト#33258 核染色法
移植部位の組織を薄切したパラフィン切片をスライドガラス(4-6μmが望ましい)に載せ、通常の脱パラフィン処理し(キシレン洗浄2回→99.9%エタノール洗浄→80%エタノール洗浄→70%エタノール洗浄→水洗)、PBS溶液に移した(この状態でしばらく置いておくことができる)。
ヘキスト#33258 (モレキュラープローブ社)4mgを1mLのPBS溶液に溶解した(アルミで遮光)。出来上がったヘキスト#33258溶液10μLを10mlのPBSで希釈し(1000倍希釈、最終濃度4μg/mL)、その数滴を平置したスライドの組織切片の上を完全に覆うように添加した。その後、室温で遮光しながら15分反応させ、5分間水洗した後、GVA Mounting Solution(グリセロール系封入剤、Zymed Lab.製、フナコシ薬品扱い)とカバーグラスで封入した。UV領域の励起が観察可能な蛍光顕微鏡の下、観察を行った。
この方法によれば、マウス細胞の核は明るく、複数のドットが観察され、その他のラット、ヒト細胞はドットが見えないので、組織の起源の種を識別できる。
図5は毛乳頭細胞がマウスに由来し、上皮系細胞がヒト(ヒト新生児包皮由来)に由来する毛包再構成系を移植した場合の蛍光顕微鏡写真の結果を、通常の組織染色、即ちヘマトキシリン−エオジン(HE)染色(「染色法のすべて」医歯薬出版株式会社、p2〜7, 1988年)した組織像との対比において示す。その図から、毛包は毛乳頭細胞(マウスに由来する明るいドットを多数有する部分)と上皮系細胞(ヒトに由来するドットを有しない部分)の双方から構成されることが明らかとなった。
Hoechst # 33258 Nuclear Staining Method Place a paraffin section sliced from the tissue at the transplant site on a slide glass (preferably 4-6μm), and perform normal deparaffinization (
Hoechst # 33258 (Molecular Probes) 4 mg was dissolved in 1 mL of PBS solution (shielded with aluminum). 10 μL of the finished Hoechst # 33258 solution was diluted with 10 ml of PBS (diluted 1000 times,
According to this method, the mouse cell nucleus is bright and a plurality of dots are observed, and other rat and human cells do not see the dots, so that the species of tissue origin can be identified.
FIG. 5 shows the results of fluorescence micrographs obtained by transplanting a hair follicle reconstitution system in which hair papilla cells are derived from mice and epithelial cells are derived from humans (derived from human newborn foreskin). -Shown in comparison with histological images stained with eosin (HE) ("All about staining", Ishiyaku Shuppan Co., Ltd., p2-7, 1988). From the figure, it was clarified that the hair follicle is composed of both dermal papilla cells (parts having many bright dots derived from mice) and epithelial cells (parts having no dots derived from humans).
3次元皮膚モデルでの毛包原基再生
ヒト線維芽細胞を0.1%コラーゲン溶液/DMEM/10%FBSに適当量分散させ、シャーレに分注し、ただちに37℃のCO2インキュベータに静置した。ゲル化後、シャーレ壁面および底面よりゲルを剥がし、シャーレの中で浮遊するようにさせた。コラーゲンゲルを揺らしながら培養し、ゲルを約5分の1に収縮させ真皮モデルとした。真皮モデルをステンレスグリッドの上に置き、その上にガラスリングをセットし、KGM(表皮細胞培養用培地)に分散したヒト培養表皮細胞(1.0 X 106 細胞数/ml)を0.4mlガラスリング内に注入し培養した。このとき、「凍結保存」マウス由来真皮細胞調製品を同時に混合して注入した。シャーレ内にDMEM―KGM―5%FBS+Ca2+の培地を、真皮モデルの上部が空気に晒される程度に入れ、培養し、約一週間後に皮膚モデルを観察し、毛包原基形成の有無と再現性を、ヘマトキシリン−エオジン染色及び上記ヘキスト染色により判定した。その結果を図6に示す。
Hair follicle primordium regeneration in a three-dimensional skin model Disperse an appropriate amount of human fibroblasts in 0.1% collagen solution / DMEM / 10% FBS, dispense into a petri dish, and immediately leave in a CO 2 incubator at 37 ° C. did. After gelation, the gel was peeled off from the petri dish wall surface and bottom, and allowed to float in the petri dish. The collagen gel was cultured while shaking, and the gel was contracted to about 1/5 to obtain a dermis model. Place the dermis model on a stainless steel grid, set a glass ring on it, 0.4 ml of human cultured epidermis cells (1.0 × 10 6 cells / ml) dispersed in KGM (medium for epidermal cell culture) It was poured into a glass ring and cultured. At this time, “cryopreserved” mouse-derived dermal cell preparations were simultaneously mixed and injected. Place the medium of DMEM-KGM-5% FBS + Ca 2+ in the petri dish so that the upper part of the dermis model is exposed to the air, and observe the skin model after about one week. Reproducibility was determined by hematoxylin-eosin staining and Hoechst staining. The result is shown in FIG.
図6の結果から明らかなとおり、本発明に係る毛包再生系を3次元皮膚モデルに移植しても、毛包原基形成が認められた。 As is apparent from the results of FIG. 6, even when the hair follicle regeneration system according to the present invention was transplanted into a three-dimensional skin model, hair follicle primordium formation was observed.
本発明に係る毛包を再生するための組成物は毛包移植や、毛包再構成についての研究・開発に利用できる。 The composition for regenerating the hair follicle according to the present invention can be used for research and development of hair follicle transplantation and hair follicle reconstruction.
Claims (22)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004048322A JP4689175B2 (en) | 2003-10-06 | 2004-02-24 | Composition, method for regenerating hair follicle and animal carrying regenerated hair follicle |
PCT/JP2004/014779 WO2005033302A1 (en) | 2003-10-06 | 2004-09-30 | Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
KR1020067008767A KR101082621B1 (en) | 2003-10-06 | 2004-09-30 | Method of preparing hair papilla cell preparation |
KR1020117016054A KR101156797B1 (en) | 2003-10-06 | 2004-09-30 | Animal having regenerated hair follicle |
EP04788471.3A EP1688484B1 (en) | 2003-10-06 | 2004-09-30 | Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
CN2004800291374A CN1863907B (en) | 2003-10-06 | 2004-09-30 | Method of preparing hair papilla cell preparation, composition and method for regenerating hair follicle and animal having regenerated hair follicle |
US10/574,697 US7718426B2 (en) | 2003-10-06 | 2004-09-30 | Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles |
KR1020117016056A KR101156868B1 (en) | 2003-10-06 | 2004-09-30 | Composition for regenerating hair follicle |
TW093130247A TWI346697B (en) | 2003-10-06 | 2004-10-06 | Method for preparing papilla cells-containing preparation |
TW100108596A TWI502069B (en) | 2003-10-06 | 2004-10-06 | Three-dimensional skin equivalent |
US12/782,284 US20100227397A1 (en) | 2003-10-06 | 2010-05-18 | Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003346939 | 2003-10-06 | ||
JP2003346939 | 2003-10-06 | ||
JP2004048322A JP4689175B2 (en) | 2003-10-06 | 2004-02-24 | Composition, method for regenerating hair follicle and animal carrying regenerated hair follicle |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005132813A JP2005132813A (en) | 2005-05-26 |
JP4689175B2 true JP4689175B2 (en) | 2011-05-25 |
Family
ID=34655913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004048322A Expired - Lifetime JP4689175B2 (en) | 2003-10-06 | 2004-02-24 | Composition, method for regenerating hair follicle and animal carrying regenerated hair follicle |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4689175B2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5258213B2 (en) * | 2006-06-27 | 2013-08-07 | 株式会社 資生堂 | Cell mass that can form primitive organs composed of multiple cell types derived from somatic |
JP5097387B2 (en) * | 2006-11-16 | 2012-12-12 | ライオン株式会社 | Artificial skin |
KR20100110905A (en) * | 2007-07-20 | 2010-10-13 | 동국대학교 산학협력단 | Method for the preparation of dermal papilla tissue employing mesenchymal stem cells |
JP5686957B2 (en) * | 2009-05-29 | 2015-03-18 | 株式会社 資生堂 | Composition for regenerating hair follicles containing CD36-expressing connective tissue sheath cells |
CN103237554B (en) | 2010-09-29 | 2015-08-12 | 株式会社资生堂 | The compositions for regenerating hair follicle containing CD36 expressivity connective tissue sheath cells |
KR102609954B1 (en) * | 2015-01-12 | 2023-12-05 | 웨이크 포리스트 유니버시티 헬스 사이언시즈 | Multilayer skin substitute products and methods of making and using the same |
JP2020080680A (en) * | 2018-11-19 | 2020-06-04 | 株式会社 資生堂 | Composition for reconstructing human skin tissue having hair follicles, human skin tissue model animal, and production method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003070466A (en) * | 2001-09-05 | 2003-03-11 | Shiseido Co Ltd | Artificial hair-bulb and method for producing the same, and method for assessing cosmetological agent by using the same |
-
2004
- 2004-02-24 JP JP2004048322A patent/JP4689175B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003070466A (en) * | 2001-09-05 | 2003-03-11 | Shiseido Co Ltd | Artificial hair-bulb and method for producing the same, and method for assessing cosmetological agent by using the same |
Also Published As
Publication number | Publication date |
---|---|
JP2005132813A (en) | 2005-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4814226B2 (en) | Preparation method of organ for transplantation | |
US20090093054A1 (en) | Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method | |
IL171595A (en) | Method for vitrification of human blastocyst-derived stem (hbs) cells or cells derived from hbs cells | |
JPWO2018038180A1 (en) | Sperm activator and use thereof | |
US20100227397A1 (en) | Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles | |
US20090186004A1 (en) | Method For Preparing An Organ For Transplantation | |
JP4689175B2 (en) | Composition, method for regenerating hair follicle and animal carrying regenerated hair follicle | |
Medvinsky et al. | Analysis and manipulation of hematopoietic progenitor and stem cells from murine embryonic tissues | |
CN1968713B (en) | Method of regenerating follicles by inhibiting gene capable of inhibiting follicle formation or activating gene capable of inducing follicle formation | |
JP2007274949A (en) | Method for culturing hair papilla cell | |
JP4264322B2 (en) | Preparation method of dermal papilla cell preparation | |
JP5164439B2 (en) | Hair papilla cell culture method | |
JPH06503001A (en) | Primordium transplants in immunocompromised hosts | |
WO2023176017A1 (en) | Oocyte maturation promoter and uses thereof | |
JP6582044B2 (en) | Method for producing frozen mesenchymal cells and method for producing therapeutic material for transplantation | |
JP2010094076A (en) | Method for freezing and preserving mammal tissue, nucleus transplantation embryo of non-human mammal and cloned non-human mammal | |
PL211680B1 (en) | Method for the deriving of MIC-1 mother cell lines from growing antlers of animals belonging to the deer family (Cervidae) | |
Reding | Thy1 is a Conserved Marker of Spermatogonial Stem Cells in the Pre-pubertal Bull Testis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060710 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100223 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100412 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110208 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110216 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4689175 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140225 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |